Empowering healthcare with AI: LungDiag NLP system transforms respiratory disease diagnosis

FHS
July 14, 2023
10:06 am

An artificial intelligence (AI) -based diagnostic system, LungDiag, to diagnose respiratory diseases.

Applied Cells opens CellQuest Research Grant to accelerate cutting-edge multiple myeloma research

Applied Cells is thrilled to announce the opening of the CellQuestGrant.

October 2, 2023

First Wave’s mid-stage trial for yeast-derived cystic fibrosis drug ‘likely’ failed, company says

First Wave BioPharma’s attempt to best the current treatment option for exocrine pancreatic insufficiency in cystic fibrosis has “likely” failed. Thursday morning, the Boca Raton,

July 14, 2023

BioLineRx’s Aphexda receives FDA approval for stem cell mobilisation

The treatment is intended for mobilising haematopoietic stem cells to peripheral blood. Credit: Terelyuk/Shutterstock.com. BioLineRx has received US Food and Drug Administration (FDA) approval for

September 12, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.